Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Yersinia Pestis; Pneumonia”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Not applicableUnknownNCT04688996
What this trial is testing

Yersinia Pestis Lateral Flow Immunoassay for Blood Samples

Who this might be right for
PlaguePlague, BubonicPlague, Pneumonic+8 more
Brimrose Technology Corporation 500
Early research (Phase 1)Looking for participantsNCT06943378
What this trial is testing

Ph1, Randomized, Double-Blind and Controlled, Dose Escalation and Expansion Study to Assess the Safety and Pharmacokinetics of JST-010 in Healthy Adults

Who this might be right for
Pre-exposure Prophylaxis Against Pneumonic Plague in Healthy Adults
Just-Evotec Biologics 104
Early research (Phase 1)Study completedNCT00097396
What this trial is testing

Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V

Who this might be right for
Pneumonic PlaguePreventive Therapy
DynPort Vaccine Company LLC, A GDIT Company 40
Large-scale testing (Phase 3)Study completedNCT04110340
What this trial is testing

Ciprofloxacin Versus an Aminoglycoside Followed by Ciprofloxacin for Bubonic Plague

Who this might be right for
Plague, BubonicPlague, Pneumonic
University of Oxford 222
Not applicableNot Yet RecruitingNCT07174648
What this trial is testing

Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo.

Who this might be right for
PlagueBubonic; Plague, SkinPlague, Pneumonic
Institute of Tropical Medicine, Belgium 300
Testing effectiveness (Phase 2)Study completedNCT05506969
What this trial is testing

Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age

Who this might be right for
Plague, PneumonicPlagueVaccine-Preventable Diseases
Dynavax Technologies Corporation 200
Large-scale testing (Phase 3)Study completedNCT00128466
What this trial is testing

Treatment and Diagnosis of Plague

Who this might be right for
Plague
Centers for Disease Control and Prevention 114
Testing effectiveness (Phase 2)Looking for participantsNCT07207408
What this trial is testing

Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age

Who this might be right for
Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis
Dynavax Technologies Corporation 148